Insiders · AGIO

Brian Goff

Chief Executive Officer, Director at Agios Pharmaceuticals, Inc. (AGIO)

Brian Goff has filed 22 insider reports with the SEC since March 2021, as chief Executive Officer and director at Agios Pharmaceuticals, Inc. (AGIO), director at Intellia Therapeutics, Inc. (NTLA) and officer at Alexion Pharmaceuticals, Inc. (ALXN). In the last 12 months Brian Goff sold $1.69M of stock on the open market. The latest filing, on June 23, 2026, reports grant or award and exercise or conversion of a derivative at Agios Pharmaceuticals, Inc. (AGIO).

Filings
22
Companies
3
Bought on market
None
Sold on market
$5.41M

Companies where Brian Goff is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Agios Pharmaceuticals, Inc. logo
AGIO
Agios Pharmaceuticals, Inc.
Chief Executive Officer, Director184,508$5.41M$28.76Jun 23, 2026
Intellia Therapeutics, Inc. logo
NTLA
Intellia Therapeutics, Inc.
Directorsince June 202432,609$9.52Jun 10, 2026
Alexion Pharmaceuticals, Inc. logo
ALXN
Alexion Pharmaceuticals, Inc.
Officer0Jul 23, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Brian Goff with

Other insiders at the same companies

Questions about Brian Goff

What is Brian Goff's role at Agios Pharmaceuticals, Inc.?
Brian Goff reports to the SEC as chief Executive Officer and director at Agios Pharmaceuticals, Inc. (AGIO), according to the latest filing on June 23, 2026. Brian Goff has also filed as director at Intellia Therapeutics, Inc. (NTLA) and officer at Alexion Pharmaceuticals, Inc. (ALXN).
How many shares does Brian Goff own?
After the latest filing that states it, Brian Goff directly owned 184,508 shares of Agios Pharmaceuticals, Inc. (AGIO) and 32,609 shares of Intellia Therapeutics, Inc. (NTLA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Brian Goff bought or sold stock recently?
The most recent open-market sale was on April 2, 2026: sold 19,068 shares of Agios Pharmaceuticals, Inc. (AGIO) for $662K at an average of $34.71.
How do I get alerts when Brian Goff files?
Follow Brian Goff on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Brian Goff (SEC CIK 0001546216). Totals count each trade once, skipping amendments whose original is on file, from Mar 2, 2021 on. View on SEC EDGAR · Get this as JSON